Skip to content

Trimethadione

Anti-epileptic Agent — NERVOUS SYSTEM

Also known as: tridione, trimetadione, trimetin

OfmFDA approvedATC N03AC02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Trimethadione is an ofm drug in the Anti-epileptic Agent class catalogued in DrugCentral. It was first approved by the FDA in 1946. DrugCentral lists 1 molecular target, including CACNA1G. Recorded indications include Absence seizure and Epilepsy.

  • Approval status: ofm (first approved 1946 by the FDA).
  • Drug class: Anti-epileptic Agent.
  • Molecular targets: CACNA1G (1 listed in DrugCentral).
  • Indications: Absence seizure and Epilepsy.
  • ATC code: N03AC02 (Oxazolidine derivatives).
  • Molecular formula: C6H9NO3; molecular weight 143.14 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Absence seizure
  • Epilepsy

Contraindications (15)

  • Acute nephropathy
  • Disease of liver
  • Disorder of optic nerve
  • Eaton-Lambert syndrome
  • Hepatic failure
  • Kidney disease
  • Leukopenia
  • Lupus erythematosus and erythema multiforme-like syndrome
  • Lymphadenopathy
  • Neutropenic disorder
  • Porphyria
  • Pregnancy, function
  • Proteinuria
  • Retinal disorder
  • Thrombocytopenic disorder

Mechanism & targets

Established pharmacologic classAnti-epileptic Agent

Molecular targets (1)

TargetGeneActionActivity
Voltage-dependent T-type calcium channel subunit alpha-1GCACNA1Gblocker—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1946-01-25FDA—ABBVIE

ATC classification

ATC codeTherapeutic hierarchy
N03AC02NERVOUS SYSTEM › ANTIEPILEPTICS › ANTIEPILEPTICS › Oxazolidine derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Trimethadione is on its molecule page.

Molecular formulaC6H9NO3
Molecular weight143.14 g/mol
CAS number127-48-0
InChIKeyIRYJRGCIQBGHIV-UHFFFAOYSA-N
PubChem CID5576
CN1C(=O)OC(C)(C)C1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Trimethadione used for?

DrugCentral lists the following indications for Trimethadione: Absence seizure and Epilepsy.

How does Trimethadione work?

Its molecular targets in DrugCentral include CACNA1G (blocker).

When was Trimethadione first approved?

Trimethadione was first approved by the FDA in 1946.

What drug class does Trimethadione belong to?

Trimethadione is in the Anti-epileptic Agent class.

What is the chemical formula of Trimethadione?

Trimethadione has the molecular formula C6H9NO3 and a molecular weight of 143.14 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1946-01-25
AgencyFDA
Targets1
Indications2
FormulaC6H9NO3
DrugCentral ID2751
Interactive profile